The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Nuchal Translucency Measurement

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Nuchal Translucency Measurement


High impact information on Nuchal Translucency Measurement


Biological context of Nuchal Translucency Measurement


Anatomical context of Nuchal Translucency Measurement


Associations of Nuchal Translucency Measurement with chemical compounds


Gene context of Nuchal Translucency Measurement


Analytical, diagnostic and therapeutic context of Nuchal Translucency Measurement


  1. Increased nuchal translucency as a marker for fetal chromosomal defects. Taipale, P., Hiilesmaa, V., Salonen, R., Ylöstalo, P. N. Engl. J. Med. (1997) [Pubmed]
  2. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Caughey, A.B., Kuppermann, M., Norton, M.E., Washington, A.E. Am. J. Obstet. Gynecol. (2002) [Pubmed]
  3. First-trimester increased nuchal translucency and fetal hypokinesia associated with Zellweger syndrome. Johnson, J.M., Babul-Hirji, R., Chitayat, D. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. (2001) [Pubmed]
  4. Increased first-trimester fetal nuchal translucency thickness in association with chondroectodermal dysplasia (Ellis-Van Creveld syndrome). Venkat-Raman, N., Sebire, N.J., Murphy, K.W., Carvalho, J.S., Hall, C.M. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. (2005) [Pubmed]
  5. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Souka, A.P., Snijders, R.J., Novakov, A., Soares, W., Nicolaides, K.H. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. (1998) [Pubmed]
  6. Increased NCAM expression and vascular development in trisomy 16 mouse embryos: relationship with nuchal translucency. Bekker, M.N., Arkesteijn, J.B., van den Akker, N.M., Hoffman, S., Webb, S., van Vugt, J.M., Gittenberger-de Groot, A.C. Pediatr. Res. (2005) [Pubmed]
  7. Pregnancy-associated plasma protein A, free human chorionic gonadotrophin and nuchal translucency as predictors of miscarriage. Rissanen, A., Niemimaa, M., Suonpää, M., Ryynänen, M., Heinonen, S. Clin. Genet. (2006) [Pubmed]
  8. First trimester screening: the BUN study. Wapner, R.J. Semin. Perinatol. (2005) [Pubmed]
  9. SURUSS in perspective. Wald, N.J., Rodeck, C., Hackshaw, A.K., Rudnicka, A. Semin. Perinatol. (2005) [Pubmed]
  10. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Krantz, D., Goetzl, L., Simpson, J.L., Thom, E., Zachary, J., Hallahan, T.W., Silver, R., Pergament, E., Platt, L.D., Filkins, K., Johnson, A., Mahoney, M., Hogge, W.A., Wilson, R.D., Mohide, P., Hershey, D., Wapner, R. Am. J. Obstet. Gynecol. (2004) [Pubmed]
  11. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia. Sebire, N.J., Snijders, R.J., Davenport, M., Greenough, A., Nicolaides, K.H. Obstetrics and gynecology. (1997) [Pubmed]
  12. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Krantz, D.A., Hallahan, T.W., Orlandi, F., Buchanan, P., Larsen, J.W., Macri, J.N. Obstetrics and gynecology. (2000) [Pubmed]
  13. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Nicolaides, K.H., Chervenak, F.A., McCullough, L.B., Avgidou, K., Papageorghiou, A. Am. J. Obstet. Gynecol. (2005) [Pubmed]
  14. First trimester screening for structural fetal abnormalities: nuchal translucency sonography. Devine, P.C., Malone, F.D. Semin. Perinatol. (1999) [Pubmed]
  15. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Zosmer, N., Souter, V.L., Chan, C.S., Huggon, I.C., Nicolaides, K.H. British journal of obstetrics and gynaecology. (1999) [Pubmed]
  16. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG. Spencer, K., Noble, P., Snijders, R.J., Nicolaides, K.H. Prenat. Diagn. (1997) [Pubmed]
  17. Down syndrome screening marker levels in women with a previous aneuploidy pregnancy. Cuckle, H.S., Spencer, K., Nicolaides, K.H. Prenat. Diagn. (2005) [Pubmed]
  18. Increased nuchal translucency in a case of long-chain 3-hydroxyacyl- coenzyme A dehydrogenase deficiency. Tercanli, S., Uyanik, G., Hösli, I., Cagdas, A., Holzgreve, W. Fetal. Diagn. Ther. (2000) [Pubmed]
  19. Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker. Rode, L., Wøjdemann, K.R., Shalmi, A.C., Larsen, S.O., Sundberg, K., Nørgaard-Pedersen, B., Christiansen, M., Tabor, A. Prenat. Diagn. (2003) [Pubmed]
  20. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. Kelekci, S., Yilmaz, B., Savan, K., Sonmez, S. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. (2005) [Pubmed]
  21. Screening for chromosomal anomalies in the first trimester: does repeat maternal serum screening improve detection rates? Spencer, K., Cuckle, H.S. Prenat. Diagn. (2002) [Pubmed]
  22. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities. Zimmermann, R., Hucha, A., Savoldelli, G., Binkert, F., Achermann, J., Grudzinskas, J.G. British journal of obstetrics and gynaecology. (1996) [Pubmed]
  23. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Hyett, J.A., Brizot, M.L., Von Kaisenberg, C.S., McKie, A.T., Farzaneh, F., Nicolaides, K.H. Obstetrics and gynecology. (1996) [Pubmed]
  24. Congenital diaphragmatic hernia. Two cases with early prenatal diagnosis and increased nuchal translucency. Varlet, F., Bousquet, F., Clemenson, A., Chauleur, C., Kopp-Dutour, N., Tronchet, M., Teyssier, G., Prieur, F., Varlet, M.N. Fetal. Diagn. Ther. (2003) [Pubmed]
  25. Maternal serum Schwangerschafts protein-1 (SP1) and fetal chromosomal abnormalities at 10-13 weeks' gestation. Brizot, M.L., Bersinger, N.A., Xydias, G., Snijders, R.J., Nicolaides, K.H. Early Hum. Dev. (1995) [Pubmed]
WikiGenes - Universities